Publications by authors named "Naoki Inui"

Claim this Profile
A
Antifibrotic therapy in familial idiopathic pulmonary fibrosis: a comparative cohort study.
Keisuke Morikawa, Yuzo Suzuki, Shinpei Kato, Masato Kono, Dai Hashimoto, Naoki Inui

Sci Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-acting muscarinic antagonist versus leukotriene receptor antagonist as additional treatment in uncontrolled asthma patients used inhaled corticosteroids and long-acting β2 adrenergic agonist: a randomized phase 2 screening trial.
Fumiya Nihashi, Kazuki Furuhashi, Mitsuru Niwa, Hirotsugu Hasegawa, Yusuke Kaida, Naoki Inui

Respir Med Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Massive immune-related myositis and cytokine release syndrome during dual immunotherapy plus chemotherapy for recurrent lung adenocarcinoma: case report.
Shogo Nakai, Yusuke Inoue, Masato Karayama, Hideki Yasui, Yuzo Suzuki, Naoki Inui

Respir Med Case Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olanzapine plus triple antiemetic therapy for prevention of carboplatin-induced nausea: a pooled analysis of two clinical trials.
Suguru Kojima, Naoki Inui, Takahito Suzuki, Kazuki Tanaka, Masato Karayama

BMC Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk stratification of acute exacerbations by autoantibodies in patients with idiopathic interstitial pneumonia.
Shusuke Yazawa, Noriyuki Enomoto, Shogo Nakai, Yasutaka Mochizuka, Atsuki Fukada, Naoki Inui

Sci Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival benefit of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung diseases: a nationwide population-based study.
Masato Karayama, Koichi Miyashita, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Naoki Inui

Thorax· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological Aging and Survival Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Receiving Systemic Therapy.
Suguru Kojima, Yusuke Inoue, Masato Karayama, Dai Hashimoto, Kazuhiro Asada, Naoki Inui

Clin Lung Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and clinical significance of acute exacerbation of interstitial lung disease in patients with primary Sjögren's syndrome.
Tomoyuki Fujisawa, Yuko Tanaka, Yosuke Kamiya, Masato Kono, Shinpei Kato, Naoki Inui

Respir Investig· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line durvalumab plus platinum-etoposide in Japanese patients with extensive-stage small-cell lung cancer.
Eisuke Mochizuki, Shun Matsuura, Naoki Koshimizu, Suguru Kojima, Shogo Sakurai, Naoki Inui

Cancer Treat Res Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individual patient data meta-analysis of NEPA versus aprepitant-based antiemetic regimens for preventing chemotherapy-induced nausea and vomiting.
Rudolph M Navari, Timothy Tyler, Naoki Inui, Hirotoshi Iihara, Erminio Bonizzoni

Future Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies.
Yusuke Inoue, Yoshihiro Kitahara, Masato Karayama, Kazuhiro Asada, Koji Nishimoto, Naoki Inui

JTO Clin Res Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Assessment of Systemic Sclerosis-Related Interstitial Lung Disease via 3D-Imaging.
Hiromasa Nakayasu, Yuzo Suzuki, Masato Kono, Dai Hashimoto, Shinpei Kato, Naoki Inui

Respirology· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depression and its association with mortality in idiopathic pulmonary fibrosis: A real-world data analysis.
Sho Takuma, Hironao Hozumi, Koichi Miyashita, Yusuke Inoue, Hideki Yasui, Naoki Inui

Respir Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alveolar Sarcoidosis Mimicking Idiopathic Interstitial Pneumonia Without Mediastinal Lymphadenopathy.
Hiroki Kanasaki, Noriyuki Enomoto, Yuko Tanaka, Suguru Kojima, Keisuke Morikawa, Naoki Inui

Respirol Case Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the relationship between bronchoalveolar lavage lymphocyte fraction and detailed autoimmune features in patients with idiopathic interstitial pneumonia.
Noriyuki Enomoto, Masayuki Watanuki, Shogo Nakai, Shusuke Yazawa, Yasutaka Mochizuka, Naoki Inui

Sci Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe drug-induced interstitial lung disease after photoimmunotherapy with cetuximab-sarotalocan sodium in a patient with oropharyngeal cancer: A case report.
Sho Takuma, Masato Karayama, Risa Suzuki, Koichi Miyashita, Yusuke Inoue, Naoki Inui

Respir Med Case Rep· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PAI-1 Inhibitor TM5441 Attenuates Emphysema and Airway Inflammation in a Murine Model of Chronic Obstructive Pulmonary Disease.
Kyohei Oishi, Hideki Yasui, Yusuke Inoue, Hironao Hozumi, Yuzo Suzuki, Naoki Inui

Int J Mol Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of serum Krebs von den Lungen-6 and surfactant protein-D levels for the diagnosis of immune checkpoint inhibitor-induced immune-related pneumonitis.
Shogo Nakai, Masato Karayama, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Naoki Inui

Respir Investig· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of arterial stiffness as assessed by the cardio-ankle vascular index in patients with chronic obstructive pulmonary disease.
Kyohei Oishi, Hideki Yasui, Yusuke Inoue, Hironao Hozumi, Yuzo Suzuki, Naoki Inui

Respir Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of renal function on non-hematologic toxicities in mCRC patients treated with TAS-102: a post-hoc analysis of the JASCC-CINV2001 study.
Hironori Fujii, Masami Tsuchiya, Daichi Watanabe, Miki Chin, Daisuke Hirate, Naoki Inui

Support Care Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of computed tomography assessment of normal lung volume in upper lobe in idiopathic pleuroparenchymal fibroelastosis.
Yuzo Suzuki, Masato Kono, Hirotsugu Hasegawa, Dai Hashimoto, Koshi Yokomura, Naoki Inui

ERJ Open Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Hyalinizing Granuloma With Favourable and Longitudinal Treatment Response.
Suguru Kojima, Noriyuki Enomoto, Keisuke Morikawa, Shogo Nakai, Shusuke Yazawa, Naoki Inui

Respirol Case Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line nivolumab plus platinum chemotherapy and bevacizumab for advanced nonsquamous non-small cell lung cancer: A 3-year follow-up of the phase 3 randomized TASUKI-52 trial.
Ki Hyeong Lee, Jong-Seok Lee, Shunichi Sugawara, Jin Hyoung Kang, Hye Ryun Kim, Naoki Inui

Lung Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lethal co-expression intolerance underlies the mutually exclusive expression of ASCL1 and NEUROD1 in SCLC cells.
Hirofumi Watanabe, Yusuke Inoue, Kazuo Tsuchiya, Kazuhiro Asada, Makoto Suzuki, Naoki Inui

NPJ Precis Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of COVID-19 in the Omicron-predominant wave: large-scale real-world data analysis with a comparison to influenza.
Koichi Miyashita, Hironao Hozumi, Kazuki Furuhashi, Eiji Nakatani, Yusuke Inoue, Naoki Inui

Pneumonia (Nathan)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis